HomeDNLI • NASDAQ
add
Denali Therapeutics Inc
Previous close
$20.70
Day range
$20.08 - $21.42
Year range
$10.57 - $23.77
Market cap
3.26B USD
Avg Volume
1.65M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 39.46M | 31.28% |
Net income | -128.55M | -12.02% |
Net profit margin | — | — |
Earnings per share | -0.73 | -8.96% |
EBITDA | -133.58M | -5.00% |
Effective tax rate | -0.08% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 867.88M | 4.27% |
Total assets | 1.14B | -16.69% |
Total liabilities | 131.09M | -9.28% |
Total equity | 1.01B | — |
Shares outstanding | 158.59M | — |
Price to book | 3.19 | — |
Return on assets | -31.21% | — |
Return on capital | -33.89% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -128.55M | -12.02% |
Cash from operations | -98.54M | -17.71% |
Cash from investing | 20.77M | -87.94% |
Cash from financing | 192.13M | 4,709.72% |
Net change in cash | 114.36M | 35.62% |
Free cash flow | -50.13M | -6.19% |
About
Founded
2013
Headquarters
Website
Employees
503
